Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative confirmatory study of K-877 versus fenofibrate
jRCT2080221722Phase 3
- Sponsor
- Kowa Company, Ltd.
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of pemafibrate in dyslipidemia (3 arms), sponsored by Kowa Company, Ltd.
02
Drugs
pemafibrate
03
Conditions
dyslipidemia
Beyond the preview
Go deeper on jRCT2080221722.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221722.